Described herein are pharmaceutical packaging programs which prevent oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate prescription drugs, these types of systems such as a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrie